UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
YuYu’s osteoporosis treatment shows fracture-preventing effects
YuYu Pharma’s treatment for osteoporosis, Maxmarvil, can help to prevent os...
by Constance Williams
|
2017-07-05 10:39
라인
Samsung BioLogics signs $55-million contract with India’s Sun Pharma
Samsung BioLogics and Sun Pharma of India have signed a contract for the pr...
by Constance Williams
|
2017-07-04 16:36
라인
Roche Korea’s anticancer drug wins FDA approval
Roche Korea said Monday that its anti-PD-L1 immunotherapy anticancer drug T...
by Constance Williams
|
2017-07-04 12:30
라인
Ministry adds warnings to hair growth solution
The Ministry of Food and Drug Safety announced plans Tuesday to revise warn...
by Marian Chu
|
2017-07-04 11:24
라인
Insurance benefit expands for Pfizer’s anti-arthritis therapy
Korea Pfizer Pharmaceutical (CEO Oh Dong-wook) said Monday the health insur...
by Constance Williams
|
2017-07-04 10:24
라인
Antipyretic Fiblast makes 4th attempt to get insurance benefits
Fiblast, a cell therapy product to treat burn injuries, will make its fourt...
by Lee Hye-seon
|
2017-07-03 17:15
라인
Regulators exclude Dong-A ST drug’s gastritis-preventing function from insurance benefits
Beginning this month, Dong-A ST will not be able to receive insurance benef...
by Lee Hye-seon
|
2017-07-03 16:10
라인
‘Orphan’ drugs emerge as new targets of pharmaceuticals
Pharmaceutical companies have been increasingly developing drugs for rare d...
by Marian Chu
|
2017-07-03 16:01
라인
Shire Korea improves its hemophilia B treatment
Shire Korea has improved the function of its Hemophilia B treatment, Rixubi...
by Constance Williams
|
2017-07-03 14:07
라인
Health industry export exceeds $10 billion for 1st time last year
Korea’s export of medicines and medical equipment exceeded $10 billion for ...
by Kwak Sung-sun
|
2017-06-30 14:11
라인
Hepatitis C treatment data presented at ‘Liver Week 2017’
Korea BMS Pharma (CEO: Park Hye-sun) presented their research of genotype 1...
by Constance Williams
|
2017-06-30 10:51
라인
Celltrion applies for FDA approval of anticancer biosimilar
The U.S. Food and Drug Administration (FDA) has accepted Celltrion’s applic...
by Constance Williams
|
2017-06-29 18:03
라인
Pfizer executive discusses social responsibility on insurance treatments
Michael Goettler, the global president of rare disease business at Pfizer, ...
by Constance Williams
|
2017-06-29 16:42
라인
Handok aims to dominate patch market with new production plant
Handok Tuesday celebrated the completion of its state-of-the-art “plaster” ...
by Marian Chu
|
2017-06-28 15:36
라인
Perfusate maker’s whim puts urologists on roller-coaster ride
The domestic urology clinics have fluctuated between hopes and fears recent...
by Song Soo-youn and Lee Hye-seon
|
2017-06-28 15:07
라인
GSK picks cell therapy, new drugs as targets of innovation
GlaxoSmithKline (GSK) said Tuesday it would focus on developing cellular an...
by Constance Williams
|
2017-06-28 13:50
라인
Il-yang exports anti-ulcer drug to Cambodia for 1st time
Il-yang Pharm (CEO: Kim Dong-yeon) has completed the first shipment of its ...
by Marian Chu
|
2017-06-28 10:50
라인
Can Korean drugmakers develop dementia therapy?
As the Moon Jae-in administration speeds up the implementation of its polic...
by Lee Hye-seon
|
2017-06-28 09:44
라인
Pharmaceutical industry most active in creating jobs
The pharmaceutical industry’s employment growth rate was far higher than ov...
by Lee Hye-seon
|
2017-06-27 18:10
라인
Why doesn’t Samsung develop new drugs?
"We are interested in developing new drugs. And we will do so, by all means...
by Lee Hye-seon
|
2017-06-26 15:57
-
이전
121
122
123
124
125
126
127
128
129
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top